Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice Journal Article


Authors: Zhao, Y.; Kuge, Y.; Zhao, S.; Morita, K.; Inubushi, M.; Strauss, H. W.; Blankenberg, F. G.; Tamaki, N.
Article Title: Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice
Abstract: Purpose: 99mTc-annexin A5, a marker of ongoing apoptosis, and 18F-FDG, a marker of the increased metabolism of inflammatory cells, are supposed to be useful in the detection of metabolically active atheroma. This study reports a comparison of the intralesional distribution of these tracers in relation to lesion development in ApoE-/- mice. Methods: Male ApoE-/- mice (n=12-14/group) were maintained on a Western-type diet after the age of 5 weeks. At 25 weeks, 99mTc-annexin A5 or 18F-FDG was injected and the aortas were harvested for autoradiography (ARG) and Oil Red O staining. Regional radioactivity accumulation was compared in relation to the Oil Red O staining score (ranging from 0 to 3, a semiquantitative parameter for evaluating lesion development). Results: Both 99mTc-annexin A5 and 18F-FDG showed preferential uptake into atherosclerotic lesions, with higher uptake levels for 18F-FDG (mean, 56.07 %ID×kg/m 2) than for 99mTc-annexin A5 (mean, 10.38 %ID×kg/m2). The regional uptake levels of each tracer correlated with the Oil Red O staining score (r=0.65, p<0.05 for 99mTc-annexin A5; r=0.56, p<0.05 for 18F-FDG). The uptake ratios of advanced lesions (score >0.5) to early lesions (score <0.5) were significantly higher for 99mTc-annexin A5 than for 18F-FDG (f=4.73, p=0.03). Conclusion: Both 99mTc-annexin A5 and 18F-FDG accumulate in atherosclerotic lesions and correlate with the severity of each lesion. The higher absolute uptake levels of 18F-FDG may be advantageous for lesion detection, whereas the preferential uptake of 99mTc-annexin A5 in advanced lesions may be a useful indicator of late-stage lesions or vulnerable plaque transformation. © 2007 Springer-Verlag.
Keywords: controlled study; unclassified drug; histopathology; nonhuman; comparative study; sensitivity and specificity; radiopharmaceuticals; reproducibility; reproducibility of results; animal cell; mouse; animal; mouse mutant; animals; mice; mice, knockout; apoptosis; animal experiment; disease model; diagnostic agent; evaluation; atherosclerosis; radioactivity; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; radiopharmaceutical agent; scintiscanning; tracer; disease models, animal; cell metabolism; autoradiography; lipocortin 5; organotechnetium compounds; 18f-fdg; apolipoprotein e; annexin a5; apolipoproteins e; 99mtc-annexin a5; apolipoprotein e-knockout mouse; annexin; annexin tc 99m; technetium complex; technetium tc 99m hynic annexin v
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 34
Issue: 11
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2007-11-01
Start Page: 1747
End Page: 1755
Language: English
DOI: 10.1007/s00259-007-0433-2
PUBMED: 17437104
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 17" - "Export Date: 17 November 2011" - "CODEN: EJNMA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harry W Strauss
    164 Strauss